SI-BONE Reports Strong Preliminary Q4 & Full Year 2025 Revenue Growth and Achieves Third Consecutive Quarter of Cashflow Breakeven
SIBN sits 52% above its 52-week low of $12.495.
Summary
SI-BONE reported strong preliminary Q4 and full year 2025 revenue growth, alongside achieving net cashflow breakeven for the third consecutive quarter and significant growth in active U.S. physicians.
Key Events · Earnings and Guidance · SIBN
-
Preliminary Q4 2025 Revenue
Reported worldwide revenue between $56.2 - $56.3 million, representing approximately 15% growth year-over-year.
-
Preliminary FY 2025 Revenue
Announced worldwide revenue between $200.8 - $200.9 million for the full fiscal year 2025, reflecting approximately 20% growth.
-
Net Cashflow Breakeven Achieved
Achieved net cashflow breakeven for the third consecutive quarter, with cash and equivalents of approximately $147.7 million.
-
Growth in Active U.S. Physicians
Increased active U.S. physicians to approximately 1,640, an 18% growth year-over-year, indicating strong market adoption.
Analysis · SIBN · Industrial Applications And Services
SI-BONE, Inc. announced robust preliminary financial results for the fourth quarter and full year 2025, demonstrating significant operational momentum. The company achieved worldwide revenue growth of approximately 15% in Q4 and 20% for the full year, indicating strong demand for its products. A key highlight is the achievement of net cashflow breakeven for the third consecutive quarter, which is a positive signal for financial stability and sustainability. The substantial increase in active U.S. physicians also points to successful market penetration and adoption of its procedural solutions. While these results are preliminary and unaudited, they provide a strong positive outlook ahead of the full earnings report.
At the time of this filing, SIBN was trading at $19.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $906M. The 52-week trading range was $12.50 to $21.89. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.